Addex Therapeutics (ADXN) Total Liabilities: 2022-2025
Historic Total Liabilities for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $1.6 million.
- Addex Therapeutics' Total Liabilities rose 35.07% to $1.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.6 million, marking a year-over-year increase of 35.07%. This contributed to the annual value of $1.1 million for FY2024, which is 70.77% down from last year.
- Addex Therapeutics' Total Liabilities amounted to $1.6 million in Q2 2025, which was up 18.13% from $1.3 million recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Total Liabilities ranged from a high of $5.4 million in Q1 2024 and a low of $1.1 million during Q4 2024.
- Over the past 3 years, Addex Therapeutics' median Total Liabilities value was $2.0 million (recorded in 2023), while the average stood at $2.5 million.
- In the last 5 years, Addex Therapeutics' Total Liabilities spiked by 54.81% in 2024 and then plummeted by 75.49% in 2025.
- Addex Therapeutics' Total Liabilities (Quarterly) stood at $3.5 million in 2022, then rose by 12.71% to $3.9 million in 2023, then plummeted by 71.01% to $1.1 million in 2024, then surged by 35.07% to $1.6 million in 2025.
- Its Total Liabilities stands at $1.6 million for Q2 2025, versus $1.3 million for Q1 2025 and $1.1 million for Q4 2024.